| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |